PanGen Biotech Inc (222110) — Free Cash Flow Generation Index

Latest as of June 2025: 0.98x

PanGen Biotech Inc (222110) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of ₩3.16 Billion represents 1% of operating cash flow (₩3.22 Billion). Explore 222110 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

₩3.16 Billion

KRW

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for PanGen Biotech Inc across 1 annual periods. For the full cash flow conversion analysis, see PanGen Biotech Inc cash conversion from operations.

Annual Free Cash Flow Generation for PanGen Biotech Inc (2024–2024)

Year-by-year Free Cash Flow Generation Index for PanGen Biotech Inc. Check PanGen Biotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2024	0.87x	₩2.61 Billion	₩2.99 Billion	₩374.12 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).